Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
KTLA

Vivlion® launches fixed-pair Alexandria, a genome-wide PRCISR™ CRISPR library with unmatched accuracy and precision

FRANKFURT, GERMANY, December 11, 2024 /EINPresswire.com/ -- Vivlion GmbH, a leader in CRISPR-based screening technologies, today announced the launch of its new ...
Morning Overview on MSN

CRISPR approach targets mitochondria to aid heart failure treatment

Rice University researchers have developed a CRISPR-based gene activation strategy that boosts mitochondrial production in damaged heart cells, improving cardiac function after heart attacks in both ...
technologynetworks

CRISPR Strategy Streamlines NGS Normalization

Watchmaker Genomics, announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, for certain foundational CRISPR-Cas9 ...